Evidence supporting the use of: Lipase
For the health condition: Pancreatitis

Links: Go back one page, Tool main page, Ingredients list, Health conditions list, Body systems list

Synopsis

Source of validity: Scientific
Rating (out of 5): 4

Lipase supplementation is scientifically validated as a treatment for pancreatic exocrine insufficiency, which frequently occurs in both acute and chronic pancreatitis. The pancreas produces digestive enzymes, including lipase, necessary for the breakdown and absorption of dietary fats. In pancreatitis, inflammation and damage to the pancreas can significantly reduce enzyme production, leading to malabsorption, steatorrhea (fatty stools), weight loss, and nutritional deficiencies.

Pancreatic enzyme replacement therapy (PERT), which includes lipase, is a standard, evidence-based medical intervention in patients with moderate to severe pancreatic insufficiency due to chronic pancreatitis. Multiple clinical guidelines and systematic reviews support the use of PERT to improve fat absorption, reduce gastrointestinal symptoms, and enhance nutritional status in affected individuals (e.g., Domínguez-Muñoz, 2011). Randomized controlled trials show that adequate dosing of lipase-containing enzyme preparations leads to significant clinical improvements.

However, in mild acute pancreatitis or in patients without documented exocrine insufficiency, routine lipase supplementation is not indicated. The therapy is tailored to documented enzyme deficiency, primarily in chronic disease. Overall, lipase is a well-established, scientifically supported therapy in pancreatitis patients with exocrine insufficiency, with clinical evidence guiding its use.

More about lipase
More about Pancreatitis